We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTG icon
8126
CALL
Heritage Insurance Holdings
HRTG
$1.01B
$163K ﹤0.01%
+10,600
New +$156K
SAN icon
8127
CALL
Banco Santander
SAN
$211B
$163K ﹤0.01%
37,148
-46,539
-56% -$209K
CCXI
8128
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
$163K ﹤0.01%
17,500
-9,000
-34% -$104K
BSET icon
8129
Bassett Furniture
BSET
$166M
$162K ﹤0.01%
10,610
-4,330
-29% -$69.5K
OIA icon
8130
Invesco Municipal Income Opportunities Trust
OIA
$294M
$162K ﹤0.01%
+21,089
New +$160K
HROW icon
8131
Harrow
HROW
$1.5B
$160K ﹤0.01%
18,480
-14,407
-44% -$79.5K
MMLP icon
8132
PUT
Martin Midstream Partners
MMLP
$93.9M
$160K ﹤0.01%
22,400
+3,800
+20% +$31.3K
CRBP icon
8133
PUT
Corbus Pharmaceuticals
CRBP
$195M
$159K ﹤0.01%
763
-5,857
-88% -$1.25M
ENLC
8134
PUT
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$159K ﹤0.01%
+15,800
New +$177K
CLLS
8135
PUT
Cellectis
CLLS
$307M
$158K ﹤0.01%
+10,100
New +$180K
FBRX icon
8136
CALL
Forte Biosciences
FBRX
$1.57B
$158K ﹤0.01%
63
-83
-57% -$246K
LSCC icon
8137
PUT
Lattice Semiconductor
LSCC
$18.5B
$158K ﹤0.01%
+10,800
New +$144K
PETX
8138
DELISTED
Aratana Therapeutics, Inc.
PETX
$158K ﹤0.01%
30,557
-8,791
-22% -$39.5K
YELL
8139
PUT
DELISTED
Yellow Corporation Common Stock
YELL
$158K ﹤0.01%
39,100
+8,800
+29% +$50.9K
CTLP
8140
PUT
DELISTED
Cantaloupe
CTLP
$157K ﹤0.01%
21,100
-30,300
-59% -$188K
XXII
8141
22nd Century Group
XXII
$1.49M
0
MEET
8142
CALL
DELISTED
The Meet Group, Inc. Common Stock
MEET
$157K ﹤0.01%
45,000
-9,300
-17% -$41.3K
MLPC
8143
DELISTED
C-Tracks ETNs based on Performance of the Miller/Howard MLP Fundamental Index
MLPC
$157K ﹤0.01%
+11,629
New +$160K
NEA icon
8144
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.4B
$156K ﹤0.01%
+11,281
New +$152K
RDNT icon
8145
RadNet
RDNT
$6.01B
$156K ﹤0.01%
11,289
-92,191
-89% -$1.18M
CYOU
8146
PUT
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$156K ﹤0.01%
16,200
-11,200
-41% -$173K
FTK icon
8147
CALL
Flotek Industries
FTK
$1.3B
$155K ﹤0.01%
7,817
+217
+3% +$4.4K
IMMR icon
8148
CALL
Immersion
IMMR
$249M
$155K ﹤0.01%
20,400
+2,900
+17% +$24.5K
SLM icon
8149
CALL
SLM Corp
SLM
$5.27B
$155K ﹤0.01%
15,900
-1,200
-7% -$11.9K
LJPC
8150
CALL
DELISTED
La Jolla Pharmaceutical Company
LJPC
$155K ﹤0.01%
16,800
+2,200
+15% +$16.6K

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.